ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2822

A Randomized Controlled Effectiveness Trial of the Enhance-Fitness® Physical Activity Program in People with Arthritis

Dina L. Jones1, Jennifer L. Eicher1, Hannah M. Ludwick2 and Kayéromi D. Gomez3, 1Orthopaedics, West Virginia University, Morgantown, WV, 2Biostatistics, West Virginia University, Morgantown, WV, 3Office of Research, University of Illinois College of Medicine at Rockford, Rockford, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Aerobic, arthritis management, exercise, physical activity and strength

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: ARHP: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: EnhanceFitness® (EF) is an evidence-based, community-delivered intervention for older adults; however, its effectiveness in people with arthritis is unknown. The purpose of this pragmatic, community-based, randomized controlled trial was to determine the effectiveness of 12 weeks of EF in improving arthritis symptoms, physical and psychosocial function, and physical activity (PA) in adults with arthritis as compared to a 12-week, wait-list control group.

Methods: Community-dwelling adults, aged 18 years or older, were eligible if they were sedentary/low-active (≤ 60 minutes/week of moderate/vigorous-intensity PA), had self-reported physician-diagnosed arthritis, and were medically cleared for exercise. Participants were randomly assigned to the EF (immediate exercise) or wait-list control group. Participants exercised thrice weekly for 12 weeks (36 classes), and completed self-reported and performance-based assessments at baseline and 12 weeks. The outcomes were arthritis symptoms (pain, stiffness, fatigue on a visual analogue scale), physical and psychosocial functioning (SF-12, Self-Efficacy Questionnaire), upper/lower extremity strength (arm curl and 5 times sit-to-stand tests), aerobic endurance (2-minute step test), functional mobility (timed up-and-go test), and PA (minutes/week and kilocalories/week for all PA, CHAMPS Physical Activity Questionnaire). Analysis of Covariance was performed to determine if outcomes improved from baseline to 12 weeks after adjusting for group, age, sex, body mass index, site (northern vs. southern state county), and outcome score at baseline. The proportion of participants meeting national PA guidelines (≥ 150 minutes/week of moderate/vigorous-intensity exercise, National Health Interview Survey Questionnaire) was compared between groups at 12 weeks using a Chi-square test.

Results: Twenty-two EF classes were held at 15 community sites in 4 urban and 5 rural counties. Of the 134 participants, 68 were randomized to EF and 66 to the control group. Participants were primarily female (87%) and white (95%), with osteoarthritis (75%) and a mean ± SD age of 67 ± 11 years (range 35-89). The EF group experienced significantly lower stiffness (Effect Size [d] -0.9, p<0.001) and fatigue (d -0.8, p=0.03), and improved performance on the arm curl (d 0.9, p<0.001) and timed up-and-go (d -0.8, p=0.03) tests at 12 weeks as compared to the control group. A significantly greater proportion of the EF group were meeting PA guidelines (67%) at 12 weeks as compared to the control group (34%) (p<0.001). There were no significant differences between groups in the remaining variables.

Conclusion: A 12-week EF program was effective in improving arthritis symptoms, upper extremity strength, functional mobility, and the proportion meeting PA guidelines in adults with self-reported arthritis. This study demonstrated that an exercise program including the four key components for reducing pain and enhancing physical function (aerobic, strengthening, balance, and flexibility exercises) can substantially improve health in adults with arthritis when delivered in real-world community settings.


Disclosure: D. L. Jones, None; J. L. Eicher, None; H. M. Ludwick, None; K. D. Gomez, None.

To cite this abstract in AMA style:

Jones DL, Eicher JL, Ludwick HM, Gomez KD. A Randomized Controlled Effectiveness Trial of the Enhance-Fitness® Physical Activity Program in People with Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-randomized-controlled-effectiveness-trial-of-the-enhance-fitness-physical-activity-program-in-people-with-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-randomized-controlled-effectiveness-trial-of-the-enhance-fitness-physical-activity-program-in-people-with-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology